Hopp til innholdet
innsidehandel
meldepliktige handler fra primærinnsidere
innsideporteføljen
innsiderne
selskapene
alle handler
ukesoppsummeringer
← Alle transaksjoner
Lytix Biopharma ASA
(LYTIX)
Kjøp
4
Salg
0
Innsidere
2
Netto siden 2021
1,5 mill. NOK
selger
kjøper
Innsidesentiment nå
Ingen fersk aktivitet
Kurs (ukentlig, 5 år) og innsidehandler
kjøp
salg
- størrelse = beløp
5
8
12
15
2022
2023
2024
2025
2026
🔔 Få e-post når innsidere handler i LYTIX
Varsle meg
Vis kun reelle kjøp og salg
Publisert
Person
Rolle
Type
Signal
Volum
Pris
Verdi
9. april 2026
Darlene Deptula-Hicks
Primary insider/Board member
Annet
Tildeling
–
100 000
0
0 kr
9. januar 2026
Brynjar Forbergskog
via Saturn Invest AS
–
Tegning
Emisjon/tegning
–
2 222 222
9
19 999 998 kr
11. desember 2025
Øystein Rekdal
CEO
Kjøp
Moderat
10 000
9,9984
99 984 kr
1. september 2025
Mette Husbyn
Chief Technology Officer
Annet
Tildeling
–
341 310
0
0 kr
1. september 2025
Gjest Breistein
CFO
Annet
Tildeling
–
615 620
0
0 kr
1. september 2025
Baldur Sveinbjørnsson
Chief Scientific Officer
Annet
Tildeling
–
923 930
0
0 kr
1. september 2025
Øystein Rekdal
CEO
Annet
Tildeling
–
1 627 860
0
0 kr
21. mai 2025
Marie-Louise Fjällskog
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
40 000
0
0 kr
21. mai 2025
Kjetil Hestdal
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
40 000
0
0 kr
21. mai 2025
Julie Dehaene-Puype
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
100 000
0
0 kr
21. mai 2025
Eric Falcand
Chair of the Board in Lytix Biopharma AS
Annet
Tildeling
–
100 000
0
0 kr
21. mai 2025
Claus Andersson
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
100 000
0
0 kr
21. mai 2025
Brynjar Forbergskog
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
40 000
0
0 kr
27. desember 2024
Brynjar Forbergskog
via Saturn Invest AS
–
Annet
Uklassifisert
–
1 318 913
0
0 kr
17. desember 2024
Brynjar Forbergskog
via Saturn Invest AS
–
Annet
Uklassifisert
–
1 318 913
0
0 kr
17. desember 2024
Øystein Rekdal
Daglig leder
Tegning
Emisjon/tegning
–
16 666
6
99 996 kr
17. desember 2024
Brynjar Forbergskog
via Saturn Invest AS
–
Tegning
Emisjon/tegning
–
3 166 666
6
18 999 996 kr
17. desember 2024
Kjetil Hestdal
Styremedlem
Tegning
Emisjon/tegning
–
13 500
6
81 000 kr
17. desember 2024
Gjest Andreas Breistein
CFO
Tegning
Emisjon/tegning
–
16 666
6
99 996 kr
17. desember 2024
Evelina Wanda Matilda Vägesjö
Styremedlem
Tegning
Emisjon/tegning
–
4 247
6
25 482 kr
17. desember 2024
Baldur Sveinbjørnsson
Chief Scientific Officer
Tegning
Emisjon/tegning
–
8 333
6
49 998 kr
26. april 2024
Brynjar Forbergsskog
via Saturn Invest AS
–
Tegning
Emisjon/tegning
–
38 910
0,1
3 891 kr
26. april 2024
Brynjar Forbergsskog
via Hifo Invest AS
–
Tegning
Emisjon/tegning
–
38 910
0,1
3 891 kr
25. april 2024
Øystein Rekdal
Daglig leder
Tegning
Emisjon/tegning
–
9 550
5,24
50 042 kr
25. april 2024
Brynjar Forbergsskog
via Saturn Invest AS
–
Tegning
Emisjon/tegning
–
724 448
5,24
3 796 108 kr
25. april 2024
Brynjar Forbergsskog
via Hifo Invest AS
–
Tegning
Emisjon/tegning
–
724 448
5,24
3 796 108 kr
25. april 2024
Gjest Andreas Breistein
CFO
Tegning
Emisjon/tegning
–
10 000
5,24
52 400 kr
25. april 2024
Baldur Sveinbjørnsson
Chief Scientific Officer
Tegning
Emisjon/tegning
–
4 000
5,24
20 960 kr
18. april 2023
Marie Roskrow 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status Chairperson of the Board in Lytix Biopharma AS
Chairperson of the Board in Lytix Biopharma AS
Annet
Tildeling
–
60 000
0
0 kr
18. april 2023
Marie-Louise Fjällskog 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status Member of the Board in Lytix Biopharma AS
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
60 000
0
0 kr
18. april 2023
Kjetil Hestdal 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status Member of the Board in Lytix Biopharma AS
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
60 000
0
0 kr
18. april 2023
Jayson Rieger 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status Member of the Board in Lytix Biopharma AS
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
60 000
0
0 kr
18. april 2023
Evelina Vågesjö 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status Member of the Board in Lytix Biopharma AS
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
60 000
0
0 kr
18. april 2023
Brynjar Forbergskog 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status Member of the Board in Lytix Biopharma AS
Member of the Board in Lytix Biopharma AS
Annet
Tildeling
–
60 000
0
0 kr
14. desember 2022
Øystein Rekdal 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status CEO in Lytix Biopharma AS
CEO in Lytix Biopharma AS
Annet
Tildeling
–
420 000
0
0 kr
14. desember 2022
Gry Stensrud 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status CTO in Lytix Biopharma AS
CTO in Lytix Biopharma AS
Annet
Tildeling
–
67 000
0
0 kr
14. desember 2022
Gjest Breistein 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status CFO in Lytix Biopharma AS
CFO in Lytix Biopharma AS
Annet
Tildeling
–
67 000
0
0 kr
14. desember 2022
Baldur Sveinbjørnsson 2222 Reason for the notificationReason for the notificationReason for the notificationReason for the notification a) Position/status CSO in Lytix Biopharma AS
CSO in Lytix Biopharma AS
Annet
Tildeling
–
100 000
0
0 kr
1. september 2022
Gert W
via North Murray AS
–
Kjøp
Moderat
33 519
8,5656
287 110 kr
27. august 2022
Gert W
via North Murray AS
–
Kjøp
Moderat
125 000
7,9714
996 425 kr
26. august 2022
Øystein Rekdal
CEO in Lytix Biopharma
Kjøp
Moderat
13 000
7,7274
100 456 kr